SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+41.76%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$164M
AUM Growth
+$164M
(+90%)
Cap. Flow
+$29M
Cap. Flow
% of AUM
17.7%
Top 10 Holdings %
Top 10 Hldgs %
48.71%
Holding
75
New
26
Increased
18
Reduced
14
Closed
15
Top Buys
| 1 |
Zymeworks
ZYME
|
$13M |
| 2 |
AstraZeneca
AZN
|
$7.2M |
| 3 |
Prothena Corp
PRTA
|
$7.06M |
| 4 |
QuidelOrtho
QDEL
|
$6.91M |
| 5 |
Sarepta Therapeutics
SRPT
|
$5.53M |
Top Sells
| 1 |
Larimar Therapeutics
LRMR
|
$16.9M |
| 2 |
Grifois
GRFS
|
$7.8M |
| 3 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$7.29M |
| 4 |
Zynex
ZYXI
|
$4.28M |
| 5 |
AGN
Allergan plc
AGN
|
$2.59M |
Sector Composition
| 1 | Healthcare | 95.78% |
| 2 | Real Estate | 0.92% |
| 3 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
26
DELISTED
NEVRO CORP.
NVRO
| $2.25M | 1.28% | +18,800 | New | +$2.25M |
|
27
Ionis Pharmaceuticals
IONS
$6.79B
| $2.15M | 1.22% | +36,400 | New | +$2.15M |
|
28
Amicus Therapeutics
FOLD
$2.34B
| $1.92M | 1.09% | 127,300 +55,300 | +77% | +$834K |
|
29
Surmodics
SRDX
$487M
| $1.9M | 1.08% | +43,978 | New | +$1.9M |
|
|
AXNX
30
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.71M | 0.98% | 48,800 -14,200 | -23% | -$498K |
|
|
HZNP
31
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.65M | 0.94% | +29,600 | New | +$1.65M |
|
32
Rafael Holdings
RFL
$51.6M
| $1.51M | 0.86% | 104,737 +15,606 | +18% | +$224K |
|
33
CRISPR Therapeutics
CRSP
$4.71B
| $1.26M | 0.72% | 17,200 +800 | +5% | +$58.8K |
|
34
STAAR Surgical
STAA
$1.36B
| $1.26M | 0.72% | 20,428 +12,630 | +162% | +$777K |
|
|
SILK
35
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.16M | 0.66% | +27,711 | New | +$1.16M |
|
36
Fate Therapeutics
FATE
$120M
| $1.13M | 0.65% | +33,000 | New | +$1.13M |
|
|
KDMN
37
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.03M | 0.59% | 200,841 -56,300 | -22% | -$288K |
|
|
BHVN
38
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.02M | 0.58% | +14,000 | New | +$1.02M |
|
|
CNST
39
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1M | 0.57% | 33,400 +15,500 | +87% | +$465K |
|
|
VAPO
40
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $889K | 0.51% | +21,700 | New | +$889K |
|
41
Dynavax Technologies
DVAX
$1.19B
| $887K | 0.51% | +100,000 | New | +$887K |
|
|
PRVB
42
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $845K | 0.48% | +59,900 | New | +$845K |
|
43
Insulet
PODD
$23.9B
| $777K | 0.44% | +4,000 | New | +$777K |
|
44
Masimo
MASI
$7.59B
| $775K | 0.44% | +3,400 | New | +$775K |
|
45
Axogen
AXGN
$743M
| $742K | 0.42% | 80,350 +5,300 | +7% | +$48.9K |
|
|
RVNC
46
DELISTED
Revance Therapeutics, Inc.
RVNC
| $695K | 0.4% | 28,469 +16,600 | +140% | +$405K |
|
47
Lyra Therapeutics
LYRA
$11.5M
| $687K | 0.39% | +60,670 | New | +$687K |
|
48
Pacira BioSciences
PCRX
$1.2B
| $640K | 0.36% | 12,200 +5,200 | +74% | +$273K |
|
|
ATRS
49
DELISTED
Antares Pharma, Inc.
ATRS
| $629K | 0.36% | 229,046 -635,054 | -73% | -$1.74M |
|
50
Biogen
BIIB
$19.4B
| $615K | 0.35% | 2,300 -700 | -23% | -$187K |
|